(Q37991128)

26 August 2017

Brentuximab vedotin: a new age in the treatment of Hodgkin lymphoma and anaplastic large cell lymphoma (English)

1 reference

26 August 2017

1 reference

Stephanie S Minich

1

1 reference

PubMed ID

22395252

26 August 2017

language of work or name

English

0 references

publication date

6 March 2012

1 reference

Annals of Pharmacotherapy

26 August 2017

1 reference

26 August 2017

46

1 reference

26 August 2017

377-383

1 reference

26 August 2017

3

1 reference

Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas

26 August 2017

1 reference

Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse.

21 January 2018

1 reference

Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma

21 January 2018

1 reference

Annual clinical updates in hematological malignancies: a continuing medical education series. Hodgkin lymphoma: 2011 update on diagnosis, risk-stratification, and management.

21 January 2018

1 reference

Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).

21 January 2018

1 reference

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

21 January 2018

1 reference

Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma

21 January 2018

1 reference

CD30: an important new target in hematologic malignancies

21 January 2018

1 reference

Anti-CD30 Antibodies for Hodgkin lymphoma.

21 January 2018

1 reference

Brentuximab Vedotin (SGN-35).

21 January 2018

1 reference

Intracellular activation of SGN-35, a potent anti-CD30 antibody-drug conjugate

21 January 2018

1 reference

CD30-targeted antibody therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1Q680

1 reference

26 August 2017

1 reference

PubMed ID

22395252